Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches Article Swipe
Vishal S. Patil
,
Chandragouda R. Patil
,
Harun Patel
,
Anoop Kumar
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fphar.2025.1480732
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3389/fphar.2025.1480732
Background Disulfiram (DSF) is an anti-alcoholic drug that has been reported to inhibit the epithelial-to-mesenchymal transition and crosslinking during fibrosis, pyroptosis, and inflammatory NF-κB and Nrf-2 signaling pathways. However, there is insufficient evidence to support the mechanisms of DSF in preventing renal fibrosis (RF). Therefore, the current study aimed to elucidate the DSF-modulated targets and pathways in renal fibrosis. Methods The common proteins between DSF and RF were screened for protein–protein interaction, pathway enrichment, cluster, and gene ontology analysis. Molecular docking was executed for core genes using AutoDock Vina through the POAP pipeline. Molecular dynamics (MD) simulation (100 ns) was performed to infer protein–ligand stability, and conformational changes were analyzed by free energy landscape (FEL). Results A total of 78 targets were found to be common between DSF and RF, of which NFKB, PIK3CA/R1 , MTOR , PTGS2 , and MMP9 were the core genes. PI3K-Akt signaling followed by JAK-STAT, TNF, Ras, ErbB, p53, phospholipase D, mTOR, IL-17, NF-κB, AMPK, VEGF, and MAPK signaling pathways were modulated by DSF in RF. DSF showed a direct binding affinity with active site residues of core genes, and except for DSF with NF-κB, all other complexes, including the standard, were found to be stable during 100 ns MD simulation with minimal protein–ligand root mean squared deviation and residual fluctuations and higher compactness with broad conformational changes. Conclusion DSF protects against renal fibrosis, and this study paves the way for experimental investigation to repurpose DSF for treating RF.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3389/fphar.2025.1480732
- https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1480732/pdf
- OA Status
- gold
- Cited By
- 4
- References
- 100
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4408581507
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4408581507Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3389/fphar.2025.1480732Digital Object Identifier
- Title
-
Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approachesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-03-18Full publication date if available
- Authors
-
Vishal S. Patil, Chandragouda R. Patil, Harun Patel, Anoop KumarList of authors in order
- Landing page
-
https://doi.org/10.3389/fphar.2025.1480732Publisher landing page
- PDF URL
-
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1480732/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1480732/pdfDirect OA link when available
- Concepts
-
Disulfiram, Medicine, Pharmacology, Computational biology, Bioinformatics, Computer science, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4Per-year citation counts (last 5 years)
- References (count)
-
100Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4408581507 |
|---|---|
| doi | https://doi.org/10.3389/fphar.2025.1480732 |
| ids.doi | https://doi.org/10.3389/fphar.2025.1480732 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40170735 |
| ids.openalex | https://openalex.org/W4408581507 |
| fwci | 18.40540199 |
| type | article |
| title | Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches |
| biblio.issue | |
| biblio.volume | 16 |
| biblio.last_page | 1480732 |
| biblio.first_page | 1480732 |
| topics[0].id | https://openalex.org/T10351 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9987999796867371 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Liver Disease Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T11207 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9876000285148621 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2734 |
| topics[1].subfield.display_name | Pathology and Forensic Medicine |
| topics[1].display_name | Alcohol Consumption and Health Effects |
| topics[2].id | https://openalex.org/T10408 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9866999983787537 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2727 |
| topics[2].subfield.display_name | Nephrology |
| topics[2].display_name | Chronic Kidney Disease and Diabetes |
| funders[0].id | https://openalex.org/F4320320720 |
| funders[0].ror | https://ror.org/0492wrx28 |
| funders[0].display_name | Indian Council of Medical Research |
| is_xpac | False |
| apc_list.value | 2950 |
| apc_list.currency | USD |
| apc_list.value_usd | 2950 |
| apc_paid.value | 2950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2950 |
| concepts[0].id | https://openalex.org/C2778523461 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7159690856933594 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q409665 |
| concepts[0].display_name | Disulfiram |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.46518510580062866 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C98274493 |
| concepts[2].level | 1 |
| concepts[2].score | 0.4325043559074402 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[2].display_name | Pharmacology |
| concepts[3].id | https://openalex.org/C70721500 |
| concepts[3].level | 1 |
| concepts[3].score | 0.41059979796409607 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[3].display_name | Computational biology |
| concepts[4].id | https://openalex.org/C60644358 |
| concepts[4].level | 1 |
| concepts[4].score | 0.3971972167491913 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q128570 |
| concepts[4].display_name | Bioinformatics |
| concepts[5].id | https://openalex.org/C41008148 |
| concepts[5].level | 0 |
| concepts[5].score | 0.32285386323928833 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[5].display_name | Computer science |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.2623606324195862 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/disulfiram |
| keywords[0].score | 0.7159690856933594 |
| keywords[0].display_name | Disulfiram |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.46518510580062866 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/pharmacology |
| keywords[2].score | 0.4325043559074402 |
| keywords[2].display_name | Pharmacology |
| keywords[3].id | https://openalex.org/keywords/computational-biology |
| keywords[3].score | 0.41059979796409607 |
| keywords[3].display_name | Computational biology |
| keywords[4].id | https://openalex.org/keywords/bioinformatics |
| keywords[4].score | 0.3971972167491913 |
| keywords[4].display_name | Bioinformatics |
| keywords[5].id | https://openalex.org/keywords/computer-science |
| keywords[5].score | 0.32285386323928833 |
| keywords[5].display_name | Computer science |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.2623606324195862 |
| keywords[6].display_name | Biology |
| language | en |
| locations[0].id | doi:10.3389/fphar.2025.1480732 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S132108250 |
| locations[0].source.issn | 1663-9812 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1663-9812 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Frontiers in Pharmacology |
| locations[0].source.host_organization | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_name | Frontiers Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320527 |
| locations[0].source.host_organization_lineage_names | Frontiers Media |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1480732/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Frontiers in Pharmacology |
| locations[0].landing_page_url | https://doi.org/10.3389/fphar.2025.1480732 |
| locations[1].id | pmid:40170735 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Frontiers in pharmacology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40170735 |
| locations[2].id | pmh:oai:doaj.org/article:146cf0d092b8427eb0a7d4d736e6de19 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Frontiers in Pharmacology, Vol 16 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/146cf0d092b8427eb0a7d4d736e6de19 |
| locations[3].id | pmh:oai:europepmc.org:10772740 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11958968 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5021662701 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-1219-1962 |
| authorships[0].author.display_name | Vishal S. Patil |
| authorships[0].countries | IN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210132590 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India |
| authorships[0].institutions[0].id | https://openalex.org/I4210132590 |
| authorships[0].institutions[0].ror | https://ror.org/03ddhrn22 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210132590 |
| authorships[0].institutions[0].country_code | IN |
| authorships[0].institutions[0].display_name | Shri Vile Parle Kelavani Mandal |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Vishal S. Patil |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India |
| authorships[1].author.id | https://openalex.org/A5075054507 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8401-1978 |
| authorships[1].author.display_name | Chandragouda R. Patil |
| authorships[1].countries | IN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210132590 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India |
| authorships[1].institutions[0].id | https://openalex.org/I4210132590 |
| authorships[1].institutions[0].ror | https://ror.org/03ddhrn22 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210132590 |
| authorships[1].institutions[0].country_code | IN |
| authorships[1].institutions[0].display_name | Shri Vile Parle Kelavani Mandal |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Chandragouda R. Patil |
| authorships[1].is_corresponding | True |
| authorships[1].raw_affiliation_strings | Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India |
| authorships[2].author.id | https://openalex.org/A5064634732 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0920-1266 |
| authorships[2].author.display_name | Harun Patel |
| authorships[2].countries | IN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210132590 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India |
| authorships[2].institutions[0].id | https://openalex.org/I4210132590 |
| authorships[2].institutions[0].ror | https://ror.org/03ddhrn22 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210132590 |
| authorships[2].institutions[0].country_code | IN |
| authorships[2].institutions[0].display_name | Shri Vile Parle Kelavani Mandal |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Harun M. Patel |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, India |
| authorships[3].author.id | https://openalex.org/A5108040058 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-4617-0307 |
| authorships[3].author.display_name | Anoop Kumar |
| authorships[3].countries | IN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I39238937 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, India |
| authorships[3].institutions[0].id | https://openalex.org/I39238937 |
| authorships[3].institutions[0].ror | https://ror.org/022akpv96 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I39238937 |
| authorships[3].institutions[0].country_code | IN |
| authorships[3].institutions[0].display_name | Delhi Pharmaceutical Science and Research University |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Anoop Kumar |
| authorships[3].is_corresponding | True |
| authorships[3].raw_affiliation_strings | Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, India |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1480732/pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Exploring disulfiram mechanisms in renal fibrosis: insights from biological data and computational approaches |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10351 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9987999796867371 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Liver Disease Diagnosis and Treatment |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W2399295483, https://openalex.org/W2158227411, https://openalex.org/W1749095546, https://openalex.org/W2029301683, https://openalex.org/W2470923949, https://openalex.org/W2066563459, https://openalex.org/W2411056736 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| locations_count | 4 |
| best_oa_location.id | doi:10.3389/fphar.2025.1480732 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S132108250 |
| best_oa_location.source.issn | 1663-9812 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1663-9812 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Frontiers in Pharmacology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_name | Frontiers Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| best_oa_location.source.host_organization_lineage_names | Frontiers Media |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1480732/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Frontiers in Pharmacology |
| best_oa_location.landing_page_url | https://doi.org/10.3389/fphar.2025.1480732 |
| primary_location.id | doi:10.3389/fphar.2025.1480732 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S132108250 |
| primary_location.source.issn | 1663-9812 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1663-9812 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Frontiers in Pharmacology |
| primary_location.source.host_organization | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_name | Frontiers Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320527 |
| primary_location.source.host_organization_lineage_names | Frontiers Media |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1480732/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Frontiers in Pharmacology |
| primary_location.landing_page_url | https://doi.org/10.3389/fphar.2025.1480732 |
| publication_date | 2025-03-18 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2885904108, https://openalex.org/W2135085018, https://openalex.org/W2600379545, https://openalex.org/W2034537627, https://openalex.org/W2040658202, https://openalex.org/W2607034643, https://openalex.org/W3203576324, https://openalex.org/W2891629413, https://openalex.org/W2347076418, https://openalex.org/W2944968176, https://openalex.org/W2177904182, https://openalex.org/W6637835351, https://openalex.org/W3209433197, https://openalex.org/W4393854155, https://openalex.org/W4200481930, https://openalex.org/W2126839635, https://openalex.org/W4226371412, https://openalex.org/W2899158325, https://openalex.org/W3093240747, https://openalex.org/W2256140926, https://openalex.org/W2038403939, https://openalex.org/W4200623125, https://openalex.org/W4327811820, https://openalex.org/W2121652706, https://openalex.org/W4388729154, https://openalex.org/W2519697102, https://openalex.org/W2175101947, https://openalex.org/W2105956434, https://openalex.org/W2788483598, https://openalex.org/W2559588208, https://openalex.org/W3200306432, https://openalex.org/W4386645574, https://openalex.org/W2899070097, https://openalex.org/W2604207380, https://openalex.org/W4220734654, https://openalex.org/W2887981960, https://openalex.org/W2131347449, https://openalex.org/W2044172327, https://openalex.org/W2129853470, https://openalex.org/W3179081715, https://openalex.org/W2104274897, https://openalex.org/W4397010745, https://openalex.org/W1983810066, https://openalex.org/W3010286796, https://openalex.org/W2606753234, https://openalex.org/W2997987934, https://openalex.org/W4400530830, https://openalex.org/W2123768693, https://openalex.org/W4221124713, https://openalex.org/W4313826159, https://openalex.org/W2096864392, https://openalex.org/W3175315525, https://openalex.org/W2264831043, https://openalex.org/W1763809381, https://openalex.org/W2050588661, https://openalex.org/W2007256917, https://openalex.org/W2110886621, https://openalex.org/W2106391842, https://openalex.org/W2973088576, https://openalex.org/W4398244737, https://openalex.org/W2045435860, https://openalex.org/W2302483302, https://openalex.org/W2921764871, https://openalex.org/W3107091804, https://openalex.org/W2521444171, https://openalex.org/W3118483304, https://openalex.org/W2766389820, https://openalex.org/W4387439282, https://openalex.org/W4383551709, https://openalex.org/W2999284120, https://openalex.org/W3195759981, https://openalex.org/W4390917638, https://openalex.org/W4211210745, https://openalex.org/W2117960153, https://openalex.org/W2792922601, https://openalex.org/W2060809301, https://openalex.org/W2030500027, https://openalex.org/W2159675211, https://openalex.org/W4394935911, https://openalex.org/W4396617860, https://openalex.org/W4231337280, https://openalex.org/W4290716764, https://openalex.org/W2474747771, https://openalex.org/W4255677297, https://openalex.org/W2134967712, https://openalex.org/W3192380806, https://openalex.org/W4381309959, https://openalex.org/W3171144462, https://openalex.org/W4286592241, https://openalex.org/W2168180694, https://openalex.org/W4394575267, https://openalex.org/W3030626861, https://openalex.org/W2084193909, https://openalex.org/W2106256269, https://openalex.org/W2109107096, https://openalex.org/W2103988494, https://openalex.org/W3153528388, https://openalex.org/W3092004032, https://openalex.org/W2468648780, https://openalex.org/W2094571796 |
| referenced_works_count | 100 |
| abstract_inverted_index., | 134, 136, 138 |
| abstract_inverted_index.A | 116 |
| abstract_inverted_index.a | 173 |
| abstract_inverted_index.78 | 119 |
| abstract_inverted_index.D, | 155 |
| abstract_inverted_index.MD | 204 |
| abstract_inverted_index.RF | 66 |
| abstract_inverted_index.an | 4 |
| abstract_inverted_index.be | 124, 199 |
| abstract_inverted_index.by | 110, 148, 167 |
| abstract_inverted_index.in | 39, 56, 169 |
| abstract_inverted_index.is | 3, 30 |
| abstract_inverted_index.ns | 203 |
| abstract_inverted_index.of | 37, 118, 130, 181 |
| abstract_inverted_index.to | 11, 33, 49, 101, 123, 198, 238 |
| abstract_inverted_index.100 | 202 |
| abstract_inverted_index.DSF | 38, 64, 127, 168, 171, 187, 224, 240 |
| abstract_inverted_index.RF, | 129 |
| abstract_inverted_index.RF. | 170, 243 |
| abstract_inverted_index.The | 60 |
| abstract_inverted_index.all | 190 |
| abstract_inverted_index.and | 16, 21, 24, 54, 65, 75, 105, 128, 139, 161, 184, 213, 216, 229 |
| abstract_inverted_index.for | 69, 83, 186, 235, 241 |
| abstract_inverted_index.has | 8 |
| abstract_inverted_index.ns) | 98 |
| abstract_inverted_index.the | 13, 35, 45, 51, 90, 142, 194, 233 |
| abstract_inverted_index.was | 81, 99 |
| abstract_inverted_index.way | 234 |
| abstract_inverted_index.(100 | 97 |
| abstract_inverted_index.(MD) | 95 |
| abstract_inverted_index.MAPK | 162 |
| abstract_inverted_index.MMP9 | 140 |
| abstract_inverted_index.MTOR | 135 |
| abstract_inverted_index.POAP | 91 |
| abstract_inverted_index.Ras, | 151 |
| abstract_inverted_index.TNF, | 150 |
| abstract_inverted_index.Vina | 88 |
| abstract_inverted_index.been | 9 |
| abstract_inverted_index.core | 84, 143, 182 |
| abstract_inverted_index.drug | 6 |
| abstract_inverted_index.free | 111 |
| abstract_inverted_index.gene | 76 |
| abstract_inverted_index.mean | 210 |
| abstract_inverted_index.p53, | 153 |
| abstract_inverted_index.root | 209 |
| abstract_inverted_index.site | 179 |
| abstract_inverted_index.that | 7 |
| abstract_inverted_index.this | 230 |
| abstract_inverted_index.were | 67, 108, 121, 141, 165, 196 |
| abstract_inverted_index.with | 177, 188, 206, 219 |
| abstract_inverted_index.(DSF) | 2 |
| abstract_inverted_index.(RF). | 43 |
| abstract_inverted_index.AMPK, | 159 |
| abstract_inverted_index.ErbB, | 152 |
| abstract_inverted_index.NFKB, | 132 |
| abstract_inverted_index.Nrf-2 | 25 |
| abstract_inverted_index.PTGS2 | 137 |
| abstract_inverted_index.VEGF, | 160 |
| abstract_inverted_index.aimed | 48 |
| abstract_inverted_index.broad | 220 |
| abstract_inverted_index.found | 122, 197 |
| abstract_inverted_index.genes | 85 |
| abstract_inverted_index.infer | 102 |
| abstract_inverted_index.mTOR, | 156 |
| abstract_inverted_index.other | 191 |
| abstract_inverted_index.paves | 232 |
| abstract_inverted_index.renal | 41, 57, 227 |
| abstract_inverted_index.study | 47, 231 |
| abstract_inverted_index.there | 29 |
| abstract_inverted_index.total | 117 |
| abstract_inverted_index.using | 86 |
| abstract_inverted_index.which | 131 |
| abstract_inverted_index.(FEL). | 114 |
| abstract_inverted_index.IL-17, | 157 |
| abstract_inverted_index.NF-κB | 23 |
| abstract_inverted_index.active | 178 |
| abstract_inverted_index.common | 61, 125 |
| abstract_inverted_index.direct | 174 |
| abstract_inverted_index.during | 18, 201 |
| abstract_inverted_index.energy | 112 |
| abstract_inverted_index.except | 185 |
| abstract_inverted_index.genes, | 183 |
| abstract_inverted_index.genes. | 144 |
| abstract_inverted_index.higher | 217 |
| abstract_inverted_index.showed | 172 |
| abstract_inverted_index.stable | 200 |
| abstract_inverted_index.Methods | 59 |
| abstract_inverted_index.NF-κB, | 158, 189 |
| abstract_inverted_index.Results | 115 |
| abstract_inverted_index.against | 226 |
| abstract_inverted_index.between | 63, 126 |
| abstract_inverted_index.binding | 175 |
| abstract_inverted_index.changes | 107 |
| abstract_inverted_index.current | 46 |
| abstract_inverted_index.docking | 80 |
| abstract_inverted_index.inhibit | 12 |
| abstract_inverted_index.minimal | 207 |
| abstract_inverted_index.pathway | 72 |
| abstract_inverted_index.squared | 211 |
| abstract_inverted_index.support | 34 |
| abstract_inverted_index.targets | 53, 120 |
| abstract_inverted_index.through | 89 |
| abstract_inverted_index.AutoDock | 87 |
| abstract_inverted_index.However, | 28 |
| abstract_inverted_index.PI3K-Akt | 145 |
| abstract_inverted_index.affinity | 176 |
| abstract_inverted_index.analyzed | 109 |
| abstract_inverted_index.changes. | 222 |
| abstract_inverted_index.cluster, | 74 |
| abstract_inverted_index.dynamics | 94 |
| abstract_inverted_index.evidence | 32 |
| abstract_inverted_index.executed | 82 |
| abstract_inverted_index.fibrosis | 42 |
| abstract_inverted_index.followed | 147 |
| abstract_inverted_index.ontology | 77 |
| abstract_inverted_index.pathways | 55, 164 |
| abstract_inverted_index.protects | 225 |
| abstract_inverted_index.proteins | 62 |
| abstract_inverted_index.reported | 10 |
| abstract_inverted_index.residual | 214 |
| abstract_inverted_index.residues | 180 |
| abstract_inverted_index.screened | 68 |
| abstract_inverted_index.treating | 242 |
| abstract_inverted_index.JAK-STAT, | 149 |
| abstract_inverted_index.Molecular | 79, 93 |
| abstract_inverted_index.PIK3CA/R1 | 133 |
| abstract_inverted_index.analysis. | 78 |
| abstract_inverted_index.deviation | 212 |
| abstract_inverted_index.elucidate | 50 |
| abstract_inverted_index.fibrosis, | 19, 228 |
| abstract_inverted_index.fibrosis. | 58 |
| abstract_inverted_index.including | 193 |
| abstract_inverted_index.landscape | 113 |
| abstract_inverted_index.modulated | 166 |
| abstract_inverted_index.pathways. | 27 |
| abstract_inverted_index.performed | 100 |
| abstract_inverted_index.pipeline. | 92 |
| abstract_inverted_index.repurpose | 239 |
| abstract_inverted_index.signaling | 26, 146, 163 |
| abstract_inverted_index.standard, | 195 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.Conclusion | 223 |
| abstract_inverted_index.Disulfiram | 1 |
| abstract_inverted_index.Therefore, | 44 |
| abstract_inverted_index.complexes, | 192 |
| abstract_inverted_index.mechanisms | 36 |
| abstract_inverted_index.preventing | 40 |
| abstract_inverted_index.simulation | 96, 205 |
| abstract_inverted_index.stability, | 104 |
| abstract_inverted_index.transition | 15 |
| abstract_inverted_index.compactness | 218 |
| abstract_inverted_index.enrichment, | 73 |
| abstract_inverted_index.pyroptosis, | 20 |
| abstract_inverted_index.crosslinking | 17 |
| abstract_inverted_index.experimental | 236 |
| abstract_inverted_index.fluctuations | 215 |
| abstract_inverted_index.inflammatory | 22 |
| abstract_inverted_index.insufficient | 31 |
| abstract_inverted_index.interaction, | 71 |
| abstract_inverted_index.DSF-modulated | 52 |
| abstract_inverted_index.investigation | 237 |
| abstract_inverted_index.phospholipase | 154 |
| abstract_inverted_index.anti-alcoholic | 5 |
| abstract_inverted_index.conformational | 106, 221 |
| abstract_inverted_index.protein–ligand | 103, 208 |
| abstract_inverted_index.protein–protein | 70 |
| abstract_inverted_index.epithelial-to-mesenchymal | 14 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5108040058, https://openalex.org/A5075054507 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 4 |
| corresponding_institution_ids | https://openalex.org/I39238937, https://openalex.org/I4210132590 |
| citation_normalized_percentile.value | 0.97639669 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |